Pseudomonas aeruginosa (PA) is a Gram-negative bacterium, often found in cystic fibrosis (CF) patients and can lead to the decline of lung functioning and premature death in 80% of infected patients when microcolonies form within the mucin of the lung. Due to its major capacity for antibiotic resistance, an alternative strategy towards defending against the bacterial invasion of PA is by the antibacterial activity of our own innate immune system with use of elements such as lysozyme. Pseudomonas aeruginosa inhibitor of vertebrate lysozyme class 1 (Ivyp1) is a periplasmic protein produced by gram-negative bacteria that inhibits the enzymatic activity of lysozyme. Previous studies have shown that Ivyp1 knockout production did not affect the growth of PA in breast milk or human saliva, however, the role of Ivy knockouts should be explored in additional lysozyme-rich environments. The aim of this project is to identify the optimal conditions for an Artificial Sputum Medium (ASM) that can most closely resemble the environment of CF lung sputum, determine what role the components of the CF lung environment have on bacterial growth between wildtype and the Ivyp1 knockout, and then determining if the restoration of the Ivyp1 knockout has some significant difference in bacterial growth patterns in comparison, within these environments as well. We propose that in the presence of lysozyme in an ASM, the absence of Ivyp1 production will reduce or impair the growth of PA. Achieving these results holds the possibility of the creation of a new therapeutic approach that targets Ivyp1 to allow the destruction of PA bacteria in the lung environment of a patient with CF by immune-response activity.
","abstract_html":"<p><em>Pseudomonas aeruginosa</em> (PA)<em> </em>is a Gram-negative bacterium, often found in cystic fibrosis (CF) patients and can lead to the decline of lung functioning and premature death in 80% of infected patients when microcolonies form within the mucin of the lung. Due to its major capacity for antibiotic resistance, an alternative strategy towards defending against the bacterial invasion of PA<em> </em>is by the antibacterial activity of our own innate immune system with use of elements such as lysozyme. <em>Pseudomonas aeruginosa </em>inhibitor of vertebrate lysozyme class 1 (Ivyp1) is a periplasmic protein produced by gram-negative bacteria that inhibits the enzymatic activity of lysozyme. Previous studies have shown that Ivyp1 knockout production did not affect the growth of PA<em> </em>in breast milk or human saliva, however, the role of Ivy knockouts should be explored in additional lysozyme-rich environments. The aim of this project is to identify the optimal conditions for an Artificial Sputum Medium (ASM) that can most closely resemble the environment of CF lung sputum, determine what role the components of the CF lung environment have on bacterial growth between wildtype and the Ivyp1 knockout, and then determining if the restoration of the Ivyp1 knockout has some significant difference in bacterial growth patterns in comparison, within these environments as well. We propose that in the presence of lysozyme in an ASM, the absence of Ivyp1 production will reduce or impair the growth of PA<em>. </em>Achieving these results holds the possibility of the creation of a new therapeutic approach that targets Ivyp1 to allow the destruction of PA<em> </em>bacteria in the lung environment of a patient with CF by immune-response activity.</p>","abstract_has_math":false,"creators":["Gaddy, Amani"],"institution":null,"degree_name":"Master of Science in Chemical Sciences (MSCB)","degree_level":"Thesis","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Thomas Leeper","Melanie Griffin","Meredith Baker"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-07-20T07:00:00Z","date_published":"2022-07-20T07:00:00Z","updated_at":"2026-07-24T02:43:58Z","subjects":["pseudomonas","Ivy","inhibitor","sputum","biofilm","lysozyme","Biochemistry","Chemistry","Microbiology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.kennesaw.edu/mscs_etd/55","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Thomas Leeper","Melanie Griffin","Meredith Baker"]},{"key":"dc:creator","label":"Author","values":["Gaddy, Amani"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-01-31T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Chemical Sciences (MSCB)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["pseudomonas","Ivy","inhibitor","sputum","biofilm","lysozyme","Biochemistry","Chemistry","Microbiology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.kennesaw.edu/mscs_etd/55"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Pseudomonas aeruginosa (PA) is a Gram-negative bacterium, often found in cystic fibrosis (CF) patients and can lead to the decline of lung functioning and premature death in 80% of infected patients when microcolonies form within the mucin of the lung. Due to its major capacity for antibiotic resistance, an alternative strategy towards defending against the bacterial invasion of PA is by the antibacterial activity of our own innate immune system with use of elements such as lysozyme. Pseudomonas aeruginosa inhibitor of vertebrate lysozyme class 1 (Ivyp1) is a periplasmic protein produced by gram-negative bacteria that inhibits the enzymatic activity of lysozyme. Previous studies have shown that Ivyp1 knockout production did not affect the growth of PA in breast milk or human saliva, however, the role of Ivy knockouts should be explored in additional lysozyme-rich environments. The aim of this project is to identify the optimal conditions for an Artificial Sputum Medium (ASM) that can most closely resemble the environment of CF lung sputum, determine what role the components of the CF lung environment have on bacterial growth between wildtype and the Ivyp1 knockout, and then determining if the restoration of the Ivyp1 knockout has some significant difference in bacterial growth patterns in comparison, within these environments as well. We propose that in the presence of lysozyme in an ASM, the absence of Ivyp1 production will reduce or impair the growth of PA. Achieving these results holds the possibility of the creation of a new therapeutic approach that targets Ivyp1 to allow the destruction of PA bacteria in the lung environment of a patient with CF by immune-response activity.
"]},{"key":"dc:title","label":"Title","values":["Growth outcomes of Pseudomonas aeruginosa inhibitor of vertebrate lysozyme knockouts in conditions mimicking the cystic fibrosis lung environment"]}]}],"canonical_facts":{"dc:contributor":["Thomas Leeper","Melanie Griffin","Meredith Baker"],"dc:creator":["Gaddy, Amani"],"dc:date.available":["2023-01-31T08:00:00Z"],"dc:description.abstract":["Pseudomonas aeruginosa (PA) is a Gram-negative bacterium, often found in cystic fibrosis (CF) patients and can lead to the decline of lung functioning and premature death in 80% of infected patients when microcolonies form within the mucin of the lung. Due to its major capacity for antibiotic resistance, an alternative strategy towards defending against the bacterial invasion of PA is by the antibacterial activity of our own innate immune system with use of elements such as lysozyme. Pseudomonas aeruginosa inhibitor of vertebrate lysozyme class 1 (Ivyp1) is a periplasmic protein produced by gram-negative bacteria that inhibits the enzymatic activity of lysozyme. Previous studies have shown that Ivyp1 knockout production did not affect the growth of PA in breast milk or human saliva, however, the role of Ivy knockouts should be explored in additional lysozyme-rich environments. The aim of this project is to identify the optimal conditions for an Artificial Sputum Medium (ASM) that can most closely resemble the environment of CF lung sputum, determine what role the components of the CF lung environment have on bacterial growth between wildtype and the Ivyp1 knockout, and then determining if the restoration of the Ivyp1 knockout has some significant difference in bacterial growth patterns in comparison, within these environments as well. We propose that in the presence of lysozyme in an ASM, the absence of Ivyp1 production will reduce or impair the growth of PA. Achieving these results holds the possibility of the creation of a new therapeutic approach that targets Ivyp1 to allow the destruction of PA bacteria in the lung environment of a patient with CF by immune-response activity.
"],"dc:identifier":["https://digitalcommons.kennesaw.edu/mscs_etd/55"],"dc:subject":["pseudomonas","Ivy","inhibitor","sputum","biofilm","lysozyme","Biochemistry","Chemistry","Microbiology"],"dc:title":["Growth outcomes of Pseudomonas aeruginosa inhibitor of vertebrate lysozyme knockouts in conditions mimicking the cystic fibrosis lung environment"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science in Chemical Sciences (MSCB)"]},"updated_at":"2026-07-24T02:43:58Z"}